Access cutting-edge von willebrand disease treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access von willebrand disease specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related von willebrand disease treatment provided free
The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) product. In this study, participants will be treated with vonicog alfa (rVWF) for 12 months. During the study, participants will visit the study clinic 5 times after treatment initiation.
Sponsor: Takeda
Check if you qualify for this von willebrand disease clinical trial in New York, NY
If you're searching for von willebrand disease treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced von willebrand disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.